108
Participants
Start Date
May 13, 2024
Primary Completion Date
March 31, 2026
Study Completion Date
March 31, 2026
Pramipexole Pill
The study drug, pramipexole, is an FDA-approved medication for the treatment of Parkinson's and restless leg syndrome. Pramipexole (Mirapex) tablets are taken orally, with or without food.
Placebo Pill
Placebo will match the study drug in mode of administration, color, size, and taste.
NOT_YET_RECRUITING
New York State Psychiatric Institute, New York
RECRUITING
University of California, San Diego, San Diego
National Institute of Mental Health (NIMH)
NIH
New York State Psychiatric Institute
OTHER
University of California, San Diego
OTHER